{"id":"https://openalex.org/W7143540918","doi":"https://doi.org/10.1038/s41541-026-01431-x","title":"Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial","display_name":"Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial","publication_year":2026,"publication_date":"2026-03-30","ids":{"openalex":"https://openalex.org/W7143540918","doi":"https://doi.org/10.1038/s41541-026-01431-x","pmid":"https://pubmed.ncbi.nlm.nih.gov/41912532","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13199437"},"language":"en","primary_location":{"id":"doi:10.1038/s41541-026-01431-x","doi":"https://doi.org/10.1038/s41541-026-01431-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41541-026-01431-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210235625","display_name":"npj Vaccines","issn_l":"2059-0105","issn":["2059-0105"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Vaccines","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1038/s41541-026-01431-x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057709751","display_name":"Kate S Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate S. Levine","raw_affiliation_strings":["Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074649837","display_name":"Ross Blanc","orcid":"https://orcid.org/0009-0007-9984-5132","observed_orcids":["https://orcid.org/0009-0007-9984-5132"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross Blanc","raw_affiliation_strings":["Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008023173","display_name":"Qixin Wang","orcid":"https://orcid.org/0000-0001-9051-8388","observed_orcids":["https://orcid.org/0000-0001-9051-8388"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qixin Wang","raw_affiliation_strings":["Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099384171","display_name":"Hadar Malca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hadar Malca","raw_affiliation_strings":["Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049742945","display_name":"Rose E. Sekulovich","orcid":"https://orcid.org/0000-0002-7590-347X","observed_orcids":["https://orcid.org/0000-0002-7590-347X"]},"institutions":[{"id":"https://openalex.org/I4210110004","display_name":"Arcturus Therapeutics (United States)","ror":"https://ror.org/01t92qx25","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rose Sekulovich","raw_affiliation_strings":["Arcturus Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcturus Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210110004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143945941","display_name":"Hongfan Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110004","display_name":"Arcturus Therapeutics (United States)","ror":"https://ror.org/01t92qx25","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongfan Jin","raw_affiliation_strings":["Arcturus Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcturus Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210110004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076159653","display_name":"Sophie N. Liu","orcid":"https://orcid.org/0000-0001-7934-8605","observed_orcids":["https://orcid.org/0000-0001-7934-8605","https://orcid.org/0009-0004-4945-8298"]},"institutions":[{"id":"https://openalex.org/I4210110004","display_name":"Arcturus Therapeutics (United States)","ror":"https://ror.org/01t92qx25","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophie Liu","raw_affiliation_strings":["Arcturus Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcturus Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210110004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002351381","display_name":"Carole Verhoeven","orcid":"https://orcid.org/0009-0000-7935-7050","observed_orcids":["https://orcid.org/0009-0000-7935-7050"]},"institutions":[{"id":"https://openalex.org/I4210110004","display_name":"Arcturus Therapeutics (United States)","ror":"https://ror.org/01t92qx25","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carole Verhoeven","raw_affiliation_strings":["Arcturus Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcturus Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210110004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022612730","display_name":"Brian Martin Sullivan","orcid":"https://orcid.org/0000-0003-4277-6037","observed_orcids":["https://orcid.org/0000-0003-4277-6037"]},"institutions":[{"id":"https://openalex.org/I4210110004","display_name":"Arcturus Therapeutics (United States)","ror":"https://ror.org/01t92qx25","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Sullivan","raw_affiliation_strings":["Arcturus Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcturus Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210110004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078223339","display_name":"Igor V. Smolenov","orcid":"https://orcid.org/0000-0002-7075-9827","observed_orcids":["https://orcid.org/0000-0002-7075-9827"]},"institutions":[{"id":"https://openalex.org/I4210110004","display_name":"Arcturus Therapeutics (United States)","ror":"https://ror.org/01t92qx25","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Igor Smolenov","raw_affiliation_strings":["Arcturus Therapeutics, San Diego, CA, USA. igor.smolenov@arcturusrx.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arcturus Therapeutics, San Diego, CA, USA. igor.smolenov@arcturusrx.com","institution_ids":["https://openalex.org/I4210110004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074894886","display_name":"Ryan P. McNamara","orcid":"https://orcid.org/0000-0002-8866-3532","observed_orcids":["https://orcid.org/0000-0002-8866-3532"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ryan P. McNamara","raw_affiliation_strings":["Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. rmcnamara@hsph.harvard.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. rmcnamara@hsph.harvard.edu","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074894886","https://openalex.org/A5078223339"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210110004"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":{"value":3890,"currency":"USD","value_usd":3890},"fwci":18.1186,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.99087183,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"11","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/self-amplifying-mrna-vaccine","display_name":"self-amplifying mRNA vaccine","score":0.9520000219345093},{"id":"https://openalex.org/keywords/bnt162b2","display_name":"BNT162b2","score":0.8650000095367432},{"id":"https://openalex.org/keywords/covid-19-vaccination","display_name":"COVID-19 vaccination","score":0.7910000085830688},{"id":"https://openalex.org/keywords/sars-cov-2-spike-protein","display_name":"SARS-CoV-2 spike protein","score":0.8690000176429749},{"id":"https://openalex.org/keywords/antibody-waning","display_name":"antibody waning","score":0.6740000247955322},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.8450000286102295},{"id":"https://openalex.org/keywords/antigenic-drift","display_name":"antigenic drift","score":0.7319999933242798},{"id":"https://openalex.org/keywords/humoral-immune-response","display_name":"humoral immune response","score":0.8560000061988831},{"id":"https://openalex.org/keywords/booster-vaccination","display_name":"booster vaccination","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6643000245094299},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6482999920845032},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6304000020027161},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.6194000244140625},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6139000058174133},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5422000288963318},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.522599995136261},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.4828999936580658},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.47909998893737793},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.47850000858306885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38109999895095825},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.38040000200271606},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.36079999804496765},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.36039999127388},{"id":"https://openalex.org/C2780441014","wikidata":"https://www.wikidata.org/wiki/Q7907952","display_name":"Vaccine efficacy","level":3,"score":0.3418999910354614},{"id":"https://openalex.org/C2778190748","wikidata":"https://www.wikidata.org/wiki/Q7907956","display_name":"Vaccine trial","level":3,"score":0.33410000801086426},{"id":"https://openalex.org/C2777648638","wikidata":"https://www.wikidata.org/wiki/Q57751738","display_name":"Coronavirus","level":5,"score":0.3257000148296356},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3190000057220459},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.295199990272522},{"id":"https://openalex.org/C2910188402","wikidata":"https://www.wikidata.org/wiki/Q85438966","display_name":"Severe acute respiratory syndrome coronavirus","level":5,"score":0.29510000348091125},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.29109999537467957},{"id":"https://openalex.org/C2776548049","wikidata":"https://www.wikidata.org/wiki/Q1142875","display_name":"Humoral immunity","level":3,"score":0.2757999897003174},{"id":"https://openalex.org/C12590561","wikidata":"https://www.wikidata.org/wiki/Q2920497","display_name":"Booster dose","level":4,"score":0.2727999985218048},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.2727999985218048},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.2646999955177307}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1038/s41541-026-01431-x","doi":"https://doi.org/10.1038/s41541-026-01431-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41541-026-01431-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210235625","display_name":"npj Vaccines","issn_l":"2059-0105","issn":["2059-0105"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Vaccines","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13199437","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13199437/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13199437/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ Vaccines","raw_type":"Text"},{"id":"pmid:41912532","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41912532","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ vaccines","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41541-026-01431-x","doi":"https://doi.org/10.1038/s41541-026-01431-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41541-026-01431-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210235625","display_name":"npj Vaccines","issn_l":"2059-0105","issn":["2059-0105"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Vaccines","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7297649257","display_name":"Arcturus Therapeutics, Inc. - To improve understanding of durability of protection after administration of nucleic-acid based vaccines","funder_award_id":"INV-080712","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"}],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"},{"id":"https://openalex.org/F4320322415","display_name":"Meiji Seika Pharma","ror":"https://ror.org/027tjex48"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7143540918.pdf","grobid_xml":"https://content.openalex.org/works/W7143540918.grobid-xml"},"referenced_works_count":72,"referenced_works":["https://openalex.org/W2032809145","https://openalex.org/W2075163956","https://openalex.org/W2080942704","https://openalex.org/W2297142125","https://openalex.org/W2585172252","https://openalex.org/W2905025253","https://openalex.org/W2920805814","https://openalex.org/W2924905929","https://openalex.org/W3047091198","https://openalex.org/W3093949211","https://openalex.org/W3111255098","https://openalex.org/W3113734454","https://openalex.org/W3126729284","https://openalex.org/W3135383916","https://openalex.org/W3148277587","https://openalex.org/W3158276912","https://openalex.org/W3163785571","https://openalex.org/W3165441111","https://openalex.org/W3169942726","https://openalex.org/W3172812363","https://openalex.org/W3189544042","https://openalex.org/W3189985782","https://openalex.org/W3200157219","https://openalex.org/W3205820418","https://openalex.org/W3216478751","https://openalex.org/W4200118071","https://openalex.org/W4200427886","https://openalex.org/W4205284298","https://openalex.org/W4206675538","https://openalex.org/W4206914007","https://openalex.org/W4210450230","https://openalex.org/W4210617949","https://openalex.org/W4220730627","https://openalex.org/W4220770600","https://openalex.org/W4220777055","https://openalex.org/W4220814092","https://openalex.org/W4225691034","https://openalex.org/W4280549613","https://openalex.org/W4282958946","https://openalex.org/W4283704819","https://openalex.org/W4288034348","https://openalex.org/W4293177414","https://openalex.org/W4302362524","https://openalex.org/W4311448444","https://openalex.org/W4311703170","https://openalex.org/W4318016227","https://openalex.org/W4319455345","https://openalex.org/W4320709105","https://openalex.org/W4323653310","https://openalex.org/W4323807147","https://openalex.org/W4361256494","https://openalex.org/W4362521382","https://openalex.org/W4365138496","https://openalex.org/W4365517147","https://openalex.org/W4366992410","https://openalex.org/W4380871243","https://openalex.org/W4384200969","https://openalex.org/W4385514758","https://openalex.org/W4385968461","https://openalex.org/W4386700321","https://openalex.org/W4386897444","https://openalex.org/W4387378343","https://openalex.org/W4387998094","https://openalex.org/W4389949010","https://openalex.org/W4389990639","https://openalex.org/W4390590955","https://openalex.org/W4390618514","https://openalex.org/W4391481393","https://openalex.org/W4402030494","https://openalex.org/W4403176378","https://openalex.org/W4403558861","https://openalex.org/W4404646505"],"related_works":["https://openalex.org/W4416718430","https://openalex.org/W6959483532","https://openalex.org/W4301181075","https://openalex.org/W4409149490","https://openalex.org/W4310177893","https://openalex.org/W4390035230","https://openalex.org/W4416447888","https://openalex.org/W4416920383","https://openalex.org/W4403666778","https://openalex.org/W4391481393"],"abstract_inverted_index":{"Sustained":[0],"and":[1,18,37,55,70,87,104,111,163,180,209,248,268,290,316],"functional":[2],"antibody":[3,51,63,143,232],"responses":[4,144,159,201],"to":[5,82,129,183,198,235,243,271],"respiratory":[6],"pathogens":[7],"through":[8,281],"vaccination":[9],"is":[10,137],"critical":[11],"for":[12,285],"global":[13],"public":[14],"health.":[15],"The":[16,46,62,279],"development":[17],"deployment":[19],"of":[20,43,77,89,106,148,176,188,194,212,252,301],"mRNA":[21,84,91,94,134,164,177],"vaccines":[22,48,96,179],"during":[23,303],"the":[24,58,74,78,83,124,225,244,265,291,298,304],"coronavirus":[25],"disease":[26],"2019":[27],"(COVID-19)":[28],"pandemic":[29],"was":[30,283,297],"a":[31,40,117,146,151,167,185,210,218,230,239,249,261,310],"landmark":[32],"achievement":[33],"in":[34,39,145,264],"modern":[35],"medicine":[36],"ushered":[38],"new":[41],"age":[42],"vaccine":[44,85,227],"innovation.":[45],"mRNA-based":[47],"elicited":[49,160,229],"strong":[50],"responses,":[52],"both":[53,286],"neutralizing":[54,157],"extra-neutralizing,":[56],"against":[57,202],"viral":[59],"Spike":[60,206,246,289],"protein.":[61],"levels":[64],"waned":[65],"with":[66,73,324],"time":[67],"since":[68],"vaccination,":[69],"that":[71,130,224],"coupled":[72],"antigenic":[75,326],"drift":[76],"virus":[79],"prompted":[80],"updates":[81],"composition":[86],"evaluation":[88],"other":[90],"modalities.":[92],"Self-amplifying":[93],"(sa-mRNA)":[95],"such":[97],"as":[98,166],"ARCT-154":[99,162,189,228,282],"can":[100,112],"prolong":[101],"antigen":[102,314],"production":[103],"durability":[105],"humoral":[107,126],"immune":[108,158,319],"response":[109,233],"post-immunization,":[110],"thus":[113],"be":[114],"administered":[115],"at":[116],"lower":[118],"dose.":[119],"How":[120],"this":[121,195,269],"translates":[122],"into":[123],"overall":[125],"architecture":[127],"compared":[128,234],"shaped":[131],"by":[132,161,238],"conventional":[133],"vaccinations,":[135],"however,":[136],"unclear.":[138],"Here,":[139],"we":[140,222],"analyze":[141],"serum-based":[142],"subset":[147],"participants":[149,171],"from":[150],"recent":[152],"Phase":[153],"III":[154],"trial":[155],"comparing":[156],"BNT162B2":[165,236],"post-hoc":[168],"research.":[169],"All":[170],"had":[172],"received":[173],"three":[174],"doses":[175],"COVID-19":[178],"were":[181,197],"randomized":[182],"receive":[184],"booster":[186],"dose":[187],"or":[190],"BNT162B2.":[191],"Primary":[192],"outcomes":[193],"research":[196],"quantify":[199],"waning":[200],"ancestral/wild":[203],"type":[204],"SARS-CoV-2":[205,214,302],"(WT":[207],"Spike)":[208],"panel":[211],"diverse":[213],"variant":[215],"Spikes.":[216,254],"Through":[217],"systems":[219],"serology":[220],"approach,":[221],"identified":[223],"sa-mRNA":[226],"unique":[231],"defined":[237],"sustained,":[240],"activating":[241,257,322],"profile":[242],"vaccine-encoded":[245],"protein":[247],"broad":[250,325],"spectrum":[251],"drifted":[253,293],"Notably,":[255],"potently":[256],"Fc\u03b3RIIIA-binding":[258],"antibodies":[259],"showed":[260],"sustained":[262],"stimulation":[263],"ARCT-154-treatment":[266],"arm,":[267],"translated":[270],"an":[272],"enhanced":[273],"natural":[274],"killer":[275],"(NK)":[276],"cell":[277],"activation.":[278],"NK-activation":[280],"present":[284],"target":[287],"WT":[288],"antigenically":[292],"BA.5":[294],"Spike,":[295],"which":[296],"predominant":[299],"form":[300],"observation":[305],"period.":[306],"Our":[307],"results":[308],"support":[309],"model":[311],"whereby":[312],"prolonged":[313],"expression":[315],"presentation":[317],"moves":[318],"profiles":[320],"towards":[321],"phenotypes":[323],"coverage.":[327]},"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-03-31T00:00:00"}